These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 15562909
21. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. Shi G, Chen X, Wang H, Wang S, Guo X, Zhang X. J Antibiot (Tokyo); 2012 May; 65(5):229-36. PubMed ID: 22334239 [Abstract] [Full Text] [Related]
22. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. Goldstein EJ, Solomkin JS, Citron DM, Alder JD. Clin Infect Dis; 2011 Dec; 53(11):1074-80. PubMed ID: 21998288 [Abstract] [Full Text] [Related]
23. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. Firsov AA, Vostrov SN, Lubenko IY, Portnoy YA, Zinner SH. Int J Antimicrob Agents; 2004 May; 23(5):451-6. PubMed ID: 15120722 [Abstract] [Full Text] [Related]
24. Antibiotic resistance in human chronic periodontitis microbiota. Rams TE, Degener JE, van Winkelhoff AJ. J Periodontol; 2014 Jan; 85(1):160-9. PubMed ID: 23688097 [Abstract] [Full Text] [Related]
25. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. J Periodontol; 2010 Jul; 81(7):964-74. PubMed ID: 20214441 [Abstract] [Full Text] [Related]
26. [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. Isla A, Canut A, Rodríguez-Gascón A, Labora A, Ardanza-Trevijano B, Solinís MA, Pedraz JL. Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):116-21. PubMed ID: 15757581 [Abstract] [Full Text] [Related]
27. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. Guentsch A, Jentsch H, Pfister W, Hoffmann T, Eick S. J Periodontol; 2008 Oct; 79(10):1894-903. PubMed ID: 18834244 [Abstract] [Full Text] [Related]
28. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. van Winkelhoff AJ, Tijhof CJ, de Graaff J. J Periodontol; 1992 Jan; 63(1):52-7. PubMed ID: 1313103 [Abstract] [Full Text] [Related]
29. Strong antibacterial effect of miswak against oral microorganisms associated with periodontitis and caries. Sofrata AH, Claesson RL, Lingström PK, Gustafsson AK. J Periodontol; 2008 Aug; 79(8):1474-9. PubMed ID: 18672998 [Abstract] [Full Text] [Related]
30. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H. J Periodontal Res; 1995 Jul; 30(4):290-3. PubMed ID: 7562327 [Abstract] [Full Text] [Related]
31. Clindamycin promotes phagocytosis and intracellular killing of periodontopathogenic bacteria by crevicular granulocytes: an in vitro study. Eick S, Pfister W, Fiedler D, Straube E. J Antimicrob Chemother; 2000 Oct; 46(4):583-8. PubMed ID: 11020256 [Abstract] [Full Text] [Related]
32. In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule. Irshad M, van der Reijden WA, Crielaard W, Laine ML. Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):469-76. PubMed ID: 22949096 [Abstract] [Full Text] [Related]
33. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. Bollen CM, Quirynen M. J Periodontol; 1996 Nov; 67(11):1143-58. PubMed ID: 8959563 [Abstract] [Full Text] [Related]
34. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. Rodríguez-Cerrato V, García P, Del Prado G, García E, Gracia M, Huelves L, Ponte C, López R, Soriano F. J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138 [Abstract] [Full Text] [Related]
35. Microbiological changes with the use of locally delivered doxycycline in the periodontal treatment of smokers. Machion L, Andia DC, Saito D, Klein MI, Gonçalves RB, Casati MZ, Nociti FH, Sallum EA. J Periodontol; 2004 Dec; 75(12):1600-4. PubMed ID: 15732860 [Abstract] [Full Text] [Related]
36. Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm. Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S. J Med Microbiol; 2014 Feb; 63(Pt 2):284-292. PubMed ID: 24217128 [Abstract] [Full Text] [Related]
37. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study. Lakhssassi N, Elhajoui N, Lodter JP, Pineill JL, Sixou M. Oral Microbiol Immunol; 2005 Aug; 20(4):244-52. PubMed ID: 15943770 [Abstract] [Full Text] [Related]
38. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. Rams TE, Listgarten MA, Slots J. J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293 [Abstract] [Full Text] [Related]
39. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Milazzo I, Blandino G, Musumeci R, Nicoletti G, Lo Bue AM, Speciale A. Int J Antimicrob Agents; 2002 Dec; 20(6):451-6. PubMed ID: 12458140 [Abstract] [Full Text] [Related]
40. [Bacteriologic investigation of periodontal infections]. Barna Z, Keglevich T, Gera I. Fogorv Sz; 2001 Jun; 94(3):97-100. PubMed ID: 11480243 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]